|
·
|
What is novel therapeutic medical devices ?
|
From the early 50’, ultrasound has expanded beyond the imaging realm, with methods and applications extending to novel therapeutic and surgical uses.
The more advance Novel systems can be combined to produce totally non-invasive therapy using HFU and UMD transducers on the same platform.
ULTRACONTOUR, patented by Medixsysteme, relies on the basic principle of HFU which is a High Focal Ultrasound beam brought to a tight focus at a distance from its source can be enhanced coupling it to a UMD (Ultrasonic Multi lymphatic drainage).
ULTRACONTOUR is undeniably the most advance tool to treat fat cells non invasively
ULTRACONTOUR is UNIQUE WITH ITS DUAL SYSTEM :
TWO KIND OF ULTRASOUNDS (HFU & UMD)
|
·
|
HFU FOCAL ULTRASOUNDS have three majors effects on FAT CELLS :
De-polymerisation or molecular dissociation of the tri-glyceride and increase their fluidity;
Lipolysis or ejection of fat acid outside of adipocyte is made via the stable cavitation phenomena and by the increase of the permeability of the adipocyte;
De fibrosis by mechanical action of the connective tissue in the hypodermis;
|
|
·
|
UMD ULTRASOUNDS to treat fat liberates in the interstitial tissue:
|
Necessity of evacuation of the waste immediately after FOCAL session, using natural lymphatic drainage otherwise human body tends to recapture approximately 80 % of those liquid waste in untreated adipocytes within few hours. Collagen stimulation.
